3-methylhistidine has been researched along with dexmedetomidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, C; Chen, Y; Cheng, M; Gao, T; Li, Q; Xi, F; Yu, W; Zhao, C | 1 |
1 other study(ies) available for 3-methylhistidine and dexmedetomidine
| Article | Year |
|---|---|
Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats.
Topics: Agouti-Related Protein; Animals; Dexmedetomidine; Endotoxemia; Hypothalamus; Inflammation; Interleukin-1; Male; Methylhistidines; Muscle, Skeletal; Muscular Atrophy; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2017 |